GSK: ViiV Healthcare Reports Superior Efficacy Of Cabotegravir For HIV Prevention In Women
positivelysharing
Reading Time: < 1minute
GlaxoSmithKline plc (GSK, GSK.L) said Monday that its majority-owned specialist HIV company ViiV Healthcare has revealed interim analysis from HPTN 084 study Read More